Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Current Leases (2021 - 2025)

Historic Current Leases for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $3.3 million.

  • Kezar Life Sciences' Current Leases fell 389.27% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 389.27%. This contributed to the annual value of $3.5 million for FY2024, which is 1706.51% up from last year.
  • Kezar Life Sciences' Current Leases amounted to $3.3 million in Q3 2025, which was down 389.27% from $3.8 million recorded in Q2 2025.
  • Kezar Life Sciences' Current Leases' 5-year high stood at $3.8 million during Q2 2025, with a 5-year trough of $1.1 million in Q1 2021.
  • In the last 5 years, Kezar Life Sciences' Current Leases had a median value of $2.8 million in 2023 and averaged $2.4 million.
  • As far as peak fluctuations go, Kezar Life Sciences' Current Leases surged by 11783.3% in 2023, and later plummeted by 389.27% in 2025.
  • Kezar Life Sciences' Current Leases (Quarter) stood at $1.2 million in 2021, then surged by 113.93% to $2.6 million in 2022, then grew by 17.43% to $3.0 million in 2023, then increased by 17.07% to $3.5 million in 2024, then dropped by 7.57% to $3.3 million in 2025.
  • Its Current Leases was $3.3 million in Q3 2025, compared to $3.8 million in Q2 2025 and $3.7 million in Q1 2025.